Health burden and funding at the Centers for Disease Control and Prevention

被引:18
|
作者
Curry, CW [1 ]
De, AK [1 ]
Ikeda, RM [1 ]
Thacker, SB [1 ]
机构
[1] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA
关键词
D O I
10.1016/j.amepre.2005.10.028
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: The relationship between domestic funding for selected conditions to the Centers for Disease Control and Prevention (CDC) and the burden of disease and disability in the United States was assessed systematically. Methods: Using mortality, years of potential life lost (YPLLs), disability-adjusted life years (DALYs), hospital days, hospital discharges, and direct medical costs of conditions, 34 high-burden conditions addressed by CDC programs were identified, and information was collected about the funds spent on each by CDC during fiscal year (FY) 2003. The 34 conditions were grouped into 15 categorical areas, and the relationship between budget and burden was anahzed using correlation and regression methods for each of the categorical areas and for each measure of burden. Results: Of CDC's total FY 2003 budget of $6.9 billion, 62% ($4.3 billion) of funding was allocated to one of the 34 conditions studied. A positive relationship between budget and burden was identified for all measures of burden, although the correlations varied for the different conditions. Conclusions: Although examination of the relationship of CDC's budget to burden measures provides insight into the agency's portfolio of investments, this exercise also highlights a number of limitations with this approach and the currently available burden measures. Assessment of key public health functions such as emergency preparedness and the collection of vital statistics require development of metrics different from the burden measures used in this analysis. Investment in the development of such metrics warrants consideration.
引用
收藏
页码:269 / 276
页数:8
相关论文
共 50 条
  • [41] News From the Centers for Disease Control and Prevention
    Kuehn, Bridget M.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 326 (10): : 902 - 902
  • [42] Thimerosal, the Centers for Disease Control and Prevention, and GlaxoSmithKline
    Verstraeten, T
    [J]. PEDIATRICS, 2004, 113 (04) : 932 - 932
  • [43] In support of the US Centers for Disease Control and Prevention
    Ghebreyesus, Tedros Adhanom
    [J]. LANCET, 2012, 379 (9826): : 1585 - 1585
  • [44] News From the Centers for Disease Control and Prevention
    Voelker, Rebecca
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 316 (14): : 1440 - 1440
  • [45] News From the Centers for Disease Control and Prevention
    Kuehn, Bridget
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 320 (24): : 2522 - 2522
  • [46] Child maltreatment prevention priorities at the Centers for Disease Control and Prevention
    Whitaker, DJ
    Lutzker, JR
    Shelley, GA
    [J]. CHILD MALTREATMENT, 2005, 10 (03) : 245 - 259
  • [47] Setting a violence prevention agenda at the Centers for Disease Control and Prevention
    Hammond, WR
    Whitaker, DJ
    Lutzker, JR
    Mercy, J
    Chin, PA
    [J]. AGGRESSION AND VIOLENT BEHAVIOR, 2006, 11 (02) : 112 - 119
  • [48] Centers for Disease Control and Prevention invest in cancer prevention programmes
    Das, Manjulika
    [J]. LANCET ONCOLOGY, 2022, 23 (07): : E320 - E320
  • [49] Building bridges - A partnership between professional nursing and the centers for disease control and prevention to reduce the burden of heart disease and stroke
    Dunbar, SB
    Mensah, GA
    Labarthe, DR
    [J]. AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2005, 29 (05) : 122 - 127
  • [50] Prevention and Control Strategies for Parasitic Infections in the Korea Centers for Disease Control and Prevention
    Bahk, Young Yil
    Shin, Eun-Hee
    Cho, Shin-Hyeong
    Ju, Jung-Won
    Chai, Jong-Yil
    Kim, Tong-Soo
    [J]. KOREAN JOURNAL OF PARASITOLOGY, 2018, 56 (05): : 401 - 408